Creo Medical Share Price | |
---|---|
Price | 34.75 |
Bid | 34.50 |
Ask | 35.00 |
Change | 0.25 (0.72%) |
Volume | 73,412 |
Open | 34.50 |
High | 34.75 |
Low | 34.50 |
Prev. Close | 34.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 361.48m |
Market Capitalisation | £125.61m |
Market Size | 5,000 |
52 Week High | 49.00 |
52 Week High Date | 02-Jan-2024 |
52 Week Low | 23.25 |
52 Week Low Date | 08-Jun-2023 |
# Trades | 20 |
---|---|
Vol. Sold | 44,867 |
Sold Value | £15.48k |
Vol. Bought | 13,545 |
Bought Value | £4.71k |
PE Ratio | -2.400459 |
Earnings | -14.4764 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
19-Apr-24 | 17:08:02 | 34.75 | 15,000 | Unknown* | 34.50 | 35.00 | 5,213 | O Ordinary Was reported as OTC |
19-Apr-24 | 15:38:12 | 34.986 | 285 | Buy* | 34.50 | 35.00 | 99.71 | O Ordinary |
19-Apr-24 | 14:20:49 | 34.70 | 15,000 | Sell* | 34.50 | 35.00 | 5,205 | O Ordinary |
19-Apr-24 | 14:20:06 | 35.00 | 2 | Buy* | 34.50 | 35.00 | 0.70 | O Ordinary Trade was executed as an SI |
19-Apr-24 | 14:20:06 | 34.50 | 119 | Sell* | 34.50 | 35.00 | 41.06 | O Ordinary Trade was executed as an SI |
19-Apr-24 | 14:20:06 | 35.00 | 571 | Buy* | 34.50 | 35.00 | 199.85 | O Ordinary Trade was executed as an SI |
19-Apr-24 | 14:20:06 | 35.00 | 14 | Buy* | 34.50 | 35.00 | 4.90 | O Ordinary Trade was executed as an SI |
19-Apr-24 | 13:31:54 | 34.70 | 3,323 | Buy* | 34.00 | 35.00 | 1,153 | O Ordinary |
19-Apr-24 | 13:27:53 | 34.70 | 1,440 | Buy* | 34.00 | 35.00 | 499.68 | O Ordinary |
19-Apr-24 | 13:20:22 | 34.72 | 3,997 | Buy* | 34.00 | 35.00 | 1,388 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
13-Mar-23 | 09-Mar-23 | Buy | Ivonne Cantu held the position of Independent Non-Executive Director at the time of this trade.Ivonne Cantu | 20.00 | GBX | 125,000 | 125,000 |
13-Mar-23 | 09-Mar-23 | Buy | John Bradshaw held the position of Independent Non-Executive Director at the time of this trade.John Bradshaw | 20.00 | GBX | 1,265,135 | 1,371,082 |
13-Mar-23 | 09-Mar-23 | Buy | David Gerard Woods held the position of Executive Director at the time of this trade.David Gerard Woods | 20.00 | GBX | 415,255 | 440,255 |
13-Mar-23 | 09-Mar-23 | Buy | Christopher Paul Hancock held the position of Chief Technology Officer at the time of this trade.Christopher Paul Hancock | 20.00 | GBX | 383,171 | 4,802,352 |
13-Mar-23 | 09-Mar-23 | Buy | Richard John Rees held the position of CFO at the time of this trade.Richard John Rees | 20.00 | GBX | 2,715,322 | 2,805,902 |